Multiple sclerosis patients see hope in Ann romney’s fight about MS using biotech drugs

Ann Romney’s poise as she addresses the Republican National Convention gives hope to 2.5 million multiple sclerosis sufferers, while showing how far biotechnology companies have come toward curing the once “untreatable” disease, experts told the Herald.

“Her own experience of living with MS has helped bring understanding about an unpredictable, chronic disease that has as many different faces and stories as the people living with it,” said Arney Rosenblat, spokeswoman for the National Multiple Sclerosis Society.

MS, which affects each sufferer differently, attacks the central nervous system and can cause numbness in the limbs, loss of vision and paralysis. Yet there are now eight drugs approved by the Food and Drug Administration designed to treat relapsing MS, Rosenblat said, adding there are also “multiple” MS therapies in late-stage development or before the FDA. 

View the original article here:  Multiple sclerosis patients see hope in Ann romney’s fight about MS using biotech drugs

ADVERTISEMENT
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend